DCM
ACHV icon

DAFNA Capital Management’s Achieve Life Sciences ACHV Stock Holding History

DAFNA Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-51
Closed -$928K – 47
2013
Q4 		$928K Buy
+51
New +$895K 0.96% 23

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DAFNA Capital Management's ACHV Position: Q1 2014 in Review

DAFNA Capital Management sold out of Achieve Life Sciences (ACHV) in Q1 2014, closing a stake of 51 shares — an estimated $928K sold.

DAFNA Capital Management first reported a position in ACHV in Q4 2013 and held it in 1 quarter. The position peaked at $928K in Q4 2013. 65 funds tracked by Wall St. Rank hold ACHV as of Q1 2014.

  • DAFNA Capital Management reported no remaining Achieve Life Sciences position as of Q1 2014 after selling out during the quarter.
  • DAFNA Capital Management sold 51 Achieve Life Sciences shares in Q1 2014, an estimated $928K.
  • DAFNA Capital Management first reported a position in Achieve Life Sciences in Q4 2013 and held it in 1 quarter.
  • DAFNA Capital Management's Achieve Life Sciences position peaked at $928K in Q4 2013.
  • 65 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2014.

Based on DAFNA Capital Management's 13F filing for Q1 2014, filed 15 May 2014.